{"id":"NCT03956355","sponsor":"Organon and Co","briefTitle":"Tapinarof for the Treatment of Plaque Psoriasis in Adults (3001)","officialTitle":"A Phase 3 Efficacy and Safety Study of Tapinarof for the Treatment of Plaque Psoriasis in Adults","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-05-21","primaryCompletion":"2020-05-26","completion":"2020-05-26","firstPosted":"2019-05-20","resultsPosted":"2022-10-13","lastUpdate":"2025-06-12"},"enrollment":510,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Plaque Psoriasis"],"interventions":[{"type":"DRUG","name":"Tapinarof","otherNames":["DMVT-505"]},{"type":"DRUG","name":"Vehicle Cream","otherNames":[]}],"arms":[{"label":"Tapinarof (DMVT-505)","type":"EXPERIMENTAL"},{"label":"Vehicle Cream","type":"PLACEBO_COMPARATOR"}],"summary":"This is a randomized, double-blind, vehicle-controlled Phase 3 study to evaluate the efficacy and safety of topical tapinarof cream, 1% once daily for the treatment of plaque psoriasis in adults. Approximately 500 adult subjects with plaque psoriasis will be randomized 2:1 to receive either tapinarof cream, 1% or matching vehicle cream once daily for 12 weeks.","primaryOutcome":{"measure":"Percent of Subjects Who Achieve a Physician Global Assessment (PGA) Score of Clear (0) or Almost Clear (1) With a Minimum 2-grade Improvement From Baseline at Week 12. Analyses Were Done Using Multiple Imputation","timeFrame":"Baseline to Week 12","effectByArm":[{"arm":"Tapinarof (DMVT-505)","deltaMin":35.4,"sd":2.75},{"arm":"Vehicle Cream","deltaMin":6,"sd":2.08}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":24},"locations":{"siteCount":53,"countries":["United States","Canada"]},"refs":{"pmids":["34879448","40600584","38123875","37697121"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":340},"commonTop":["Folliculitis","Nasopharyngitis","Dermatitis contact","Headache","Upper respiratory tract infection"]}}